Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Illumina, Inc. - Common Stock (NQ:ILMN)

145.00 -0.70 (-0.48%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Illumina, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
37 38 Next >
News headline image
PacBio (PACB) Q1 2026 Earnings Call Transcript ↗
PacBio (PACB) Q1 2026 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
5 Revealing Analyst Questions From Illumina’s Q1 Earnings Call
Illumina’s first quarter reflected consistent execution across its clinical and instrument businesses. Management highlighted strong demand in clinical seque... 
Via StockStory
Topics Earnings
News headline image
3 Profitable Stocks We’re Skeptical Of
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does... 
Via StockStory
Illumina Q1 2026 Earnings Beat Overshadowed by Revenue Miss, ILMN Slides ↗
Via Chartmill
Topics Earnings
News headline image
10x Genomics (TXG) Reports Earnings Tomorrow: What To Expect
Biotech company 10x Genomics (NASDAQ:TXG) will be announcing earnings results this Thursday after the bell. Here’s what to look for. 10x Genomics beat analys... 
Via StockStory
News headline image
PacBio (PACB) Q1 Earnings Report Preview: What To Look For
Genomics company Pacific Biosciences of California (NASDAQ:PACB) will be reporting earnings this Thursday after market hours. Here’s what investors should kn... 
Via StockStory
News headline image
Uber, Exxon Mobil, Illumina, Diamondback Energy: CNBC's 'Final Trades' ↗
CNBC's Halftime Report Final Trades featured Bryn Talkington's final trade of Uber, whose shares fell 1.6% to close at $73.93 on Monday. 
Via Benzinga
News headline image
ILMN Q1 Deep Dive: Clinical Sequencing Fuels Growth as NovaSeq X Demand Surges
Genomics company Illumina (NASDAQ:ILMN) reported Q1 CY2026 results exceeding the market’s revenue expectations, with sales up 4.8% year on year to $1.09 bill... 
Via StockStory
News headline image
Illumina (ILMN) Q1 2026 Earnings Transcript ↗
Illumina (ILMN) Q1 2026 Earnings Transcript 
Via The Motley Fool
News headline image
Illumina (NASDAQ:ILMN) Posts Better-Than-Expected Sales In Q1 CY2026
Genomics company Illumina (NASDAQ:ILMN) reported Q1 CY2026 results beating Wall Street’s revenue expectations, with sales up 4.8% year on year to $1.09 billi... 
Via StockStory
News headline image
Illumina (ILMN) Q1 Earnings Report Preview: What To Look For
Genomics company Illumina (NASDAQ:ILMN) will be reporting earnings this Thursday afternoon. Here’s what to look for. Illumina beat analysts’ revenue expectat... 
Via StockStory
Topics Artificial Intelligence
News headline image
UPS, Netflix, BlackRock And A Health Care Stock On CNBC's 'Final Trades' ↗
Stephen Weiss recommends Netflix as final trade, while Jason Snipe likes BlackRock. Amy Raskin suggests Illumina and Jenny Harrington chooses UPS. 
Via Benzinga
News headline image
Consolidation Fever: Boston Scientific’s $14.9 Billion Bet on Penumbra Signals New Era in MedTech M&A
In a move that has sent shockwaves through the healthcare sector, Boston Scientific Corporation (NYSE: BSX) announced its definitive agreement to acquire Penumbra, Inc. (NYSE: PEN) for approximately... 
Via MarketMinute
Topics Economy
News headline image
3 Unpopular Stocks That Concern Us
When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fea... 
Via StockStory
News headline image
3 Reasons to Avoid ILMN and 1 Stock to Buy Instead
In a sliding market, Illumina has defied the odds, trading up to $126.99 per share. Its 31.7% gain since October 2025 has outpaced the S&P 500’s 1.8% drop. T... 
Via StockStory
Topics Stocks
News headline image
1 Mid-Cap Stock for Long-Term Investors and 2 We Brush Off
Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to beco... 
Via StockStory
News headline image
Nasdaq Overhauls Index Rules to Capture Mega-Cap IPOs: The Era of 'Fast Entry' and Phantom Market Caps Begins
On March 30, 2026, Nasdaq (Nasdaq: NDAQ) announced the finalization of the most significant methodology overhaul to its flagship Nasdaq-100 Index in over a decade. Set to take effect on May 1, 2026,... 
Via MarketMinute
Topics Artificial Intelligence ETFs Economy
News headline image
RadNet, Evolent Health, Illumina, Charles River Laboratories, and Repligen Stocks Trade Down, What You Need To Know
What Happened? A number of stocks fell in the afternoon session after major indices including the S&P 500 and Dow Jones Industrial Average fell sharply as in... 
Via StockStory
Topics Economy Government Stocks
News headline image
A $175 Million Move Into Sotera Health Signals Potential Opportunity Amid 21% Stock Drop ↗
Sotera Health delivers sterilization and lab testing services to global medical and pharmaceutical supply chains. 
Via The Motley Fool
News headline image
Abbott Laboratories Finalizes $21 Billion Acquisition of Exact Sciences, Redefining the Future of Cancer Diagnostics
CHICAGO — In a move that fundamentally reshapes the global diagnostics landscape, Abbott Laboratories (NYSE: ABT) officially completed its $21 billion acquisition of Exact Sciences (NASDAQ: EXAS)... 
Via MarketMinute
Topics Supply Chain
News headline image
Life Sciences Tools & Services Stocks Q4 Earnings: Illumina (NASDAQ:ILMN) Firing on All Cylinders
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Illumina (NASDAQ:ILMN) and it... 
Via StockStory
Topics Artificial Intelligence
News headline image
ADS and Gamma Scientific Release Joint White Paper on Practical Path to NHTSA ADB Compliance
Via PRLog
News headline image
Illumina Stock Sees RS Rating Jump To 82 ↗
One key metric to look for in a stock is an 80-plus Relative Strength Rating. Illumina stock cleared that benchmark Monday, jumping to 82. 
Via Investor's Business Daily
News headline image
3 Profitable Stocks with Open Questions
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifi... 
Via StockStory
News headline image
Life Sciences Tools & Services Stocks Q4 In Review: 10x Genomics (NASDAQ:TXG) Vs Peers
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the life sciences tools & services stocks, including 10x Genomics (NASDAQ:TXG) and its ... 
Via StockStory
Topics Artificial Intelligence
News headline image
Life Sciences Tools & Services Stocks Q4 Recap: Benchmarking PacBio (NASDAQ:PACB)
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at PacBio (NASDAQ:PACB) and its ... 
Via StockStory
Topics Artificial Intelligence
News headline image
The "Flight to Quality": Thermo Fisher’s Q4 Beat and Dividend Hike Cement Defensive Leadership for 2026
WALTHAM, MA — In a market defined by shifting geopolitical alliances and a renewed "flight to quality," Thermo Fisher Scientific (NYSE:TMO) has once again asserted its dominance as the bedrock of the... 
Via MarketMinute
Topics Earnings Economy World Trade
News headline image
What a $75 Million Exit From MDU Might Signal Amid a 24% One-Year Rally ↗
MDU Resources Group supplies regulated utilities and construction services across the U.S., with consistent revenue and a stable dividend. 
Via The Motley Fool
Topics Energy
News headline image
1 Healthcare Stock Worth Your Attention and 2 Facing Challenges
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from elevated demand, and their momentum is only... 
Via StockStory
Topics Stocks
News headline image
5 Insightful Analyst Questions From Illumina’s Q4 Earnings Call
Illumina’s fourth quarter was marked by strong performance in its clinical consumables business, with management citing 20% year-over-year growth outside China as a key driver. CEO Jacob Thaysen... 
Via StockStory
Topics Earnings
< Previous 1 2 3 4 5 6 7 8 9
...
37 38 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.